NYSE American - Delayed Quote USD

Cryo-Cell International, Inc. (CCEL)

7.40

+0.15

+(2.07%)

At close: January 14 at 3:56:43 PM EST

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

OLDSMAR, Fla., October 30, 2024--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) ("Cryo-Cell"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that its Board of Directors has approved the payment of a regular quarterly cash dividend at an initial rate of $0.25 per share of common stock to be paid to its shareholders of record as of the close of business on November 15, 2024. The dividend is expected to be paid on November 29, 20

Business Wire 2 months ago

CCEL
+2.07%
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

OLDSMAR, Fla., October 15, 2024--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2024.

Business Wire 2 months ago

CCEL
+2.07%
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

OLDSMAR, Fla., July 15, 2024--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2024.

Business Wire 5 months ago

CCEL
+2.07%
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

OLDSMAR, Fla., April 15, 2024--Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 29, 2024.

Business Wire 8 months ago

CCEL
+2.07%
Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

OLDSMAR, Fla., March 25, 2024--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company" or "Cryo-Cell"), the world’s first private cord blood bank to separate and store stem cells in 1992, today announced that its Board of Directors has authorized the spin-off of its newly formed subsidiary, Celle Corp., to the Cryo-Cell shareholders and to explore all strategic alternatives for Cryo-Cell (post spin-off) to maximize shareholder value, including, but not limited to, equity and/or de

Business Wire 9 months ago

CCEL
+2.07%
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

OLDSMAR, Fla., February 28, 2024--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2023.

Business Wire 10 months ago

CCEL
+2.07%
Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 24th, & Thursday, January 25th, 2024, starting at 9:00 a.m. ET. We will be presenting our 2024 Healthcare IT Virtual Conference. Allen Klee, Senior Research Analyst at Maxim Grou

GlobeNewswire 11 months ago

CDXFF

DOCRF

MRAI

Performance Overview

Return	CCEL	S&P 500
YTD	0.00%	-1.08%
1-Year	+30.45%	+22.14%
3-Year	-24.21%	+25.41%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cryo-Cell International, Inc. (CCEL)

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

Performance Overview